Home oxygen therapy as model of Medicare cost-control touted by Apria's Rapp.
This article was originally published in The Gray Sheet
Executive Summary
HOME OXYGEN THERAPY AS MEDICARE COST-CONTROL MODEL touted by Richard Rapp, senior VP of Apria Healthcare, at a House Ways and Means/Health Subcommittee hearing July 25 on Medicare reform. "The current structure of reimbursement of home oxygen services offers a model for utilization and cost controls that can be applied to other parts of Medicare" currently served on a fee reimbursement basis, Rapp said.